Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
J-Long Group | JL | Jan 17, 2025 | 5.31 | -12.09 |
J. W. Mays | MAYS | Jan 17, 2025 | 44.00 | 0.00 |
J.B. Hunt Transport Services | JBHT | Jan 17, 2025 | 172.45 | -7.38 |
J.Jill | JILL | Jan 17, 2025 | 27.29 | +1.75 |
Jabil | JBL | Jan 17, 2025 | 162.90 | +0.72 |
Jack Henry & Associates | JKHY | Jan 17, 2025 | 173.16 | +0.38 |
Jack In The Box | JACK | Jan 17, 2025 | 38.66 | -2.18 |
Jackson Financial | JXN | Jan 17, 2025 | 92.58 | +0.16 |
Jackson Financial | JXN-A | Jan 17, 2025 | 26.25 | -1.06 |
Jacobs Engineering Group | J | Jan 17, 2025 | 139.26 | +0.67 |
Jaguar Health | JAGX | Jan 17, 2025 | 0.85 | -1.69 |
JAKKS Pacific | JAKK | Jan 17, 2025 | 27.70 | +1.58 |
James Hardie Industries ADR | JHX | Jan 17, 2025 | 33.83 | -1.26 |
James River Group Holdings | JRVR | Jan 17, 2025 | 4.79 | +0.42 |
Jamf | JAMF | Jan 17, 2025 | 14.40 | +1.69 |
Janover | JNVR | Jan 17, 2025 | 5.50 | +5.57 |
Janus Henderson Group | JHG | Jan 17, 2025 | 42.86 | +1.83 |
Janus International Group | JBI | Jan 17, 2025 | 7.60 | +5.26 |
Janus Small Cap Growth Alpha ETF | JSML | Jan 17, 2025 | 68.02 | +0.25 |
Janus Small/Mid Cap Growth Alpha ETF | JSMD | Jan 17, 2025 | 77.17 | +0.26 |
Janux Therapeutics | JANX | Jan 17, 2025 | 40.72 | +0.27 |
Japan Alphadex First Trust | FJP | Jan 17, 2025 | 50.47 | +0.76 |
Japan Hedged Equity Wisdomtree | DXJ | Jan 17, 2025 | 107.70 | +1.16 |
Japan Index MSCI Ishares | EWJ | Jan 17, 2025 | 66.18 | +0.50 |
Japan Smallcap Dividend Wisdomtree | DFJ | Jan 17, 2025 | 73.39 | -0.03 |
Japan Smallcap Index MSCI Ishares | SCJ | Jan 17, 2025 | 72.02 | +0.41 |
Japan Smaller Capitalization Fund | JOF | Jan 17, 2025 | 7.53 | +0.13 |
Japanese Yen Trust | FXY | Jan 17, 2025 | 59.14 | -0.55 |
Jasper Therapeutics A | JSPR | Jan 17, 2025 | 5.51 | +3.18 |
Jayud Global Logistics | JYD | Jan 17, 2025 | 2.65 | +9.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.